Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000470082 | SCV000559890 | likely benign | Adams-Oliver syndrome 5 | 2024-11-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001552411 | SCV001773090 | likely benign | not provided | 2021-04-09 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000470082 | SCV002554480 | likely benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270525 | SCV002554481 | likely benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002350026 | SCV002619350 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2021-03-04 | criteria provided, single submitter | clinical testing | The c.3644-5C>T intronic variant results from a C to T substitution 5 nucleotides upstream from coding exon 23 in the NOTCH1 gene. This nucleotide position is poorly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004541486 | SCV004785528 | likely benign | NOTCH1-related disorder | 2020-04-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |